Rallybio Corporation (RLYB) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 53.49M | 61.25M | 66.63M | 50.27M | 57.38M | 67.84M | 78.23M | 91.44M | 98.55M | 114.79M | 132.42M | 146.83M |
| Cash & Short-Term Investments | 46.8M | 54.74M | 59.32M | 45.75M | 54.49M | 65.51M | 75.14M | 88.61M | 94.17M | 109.93M | 121.38M | 137.84M |
| Cash Only | 41.3M | 31.37M | 32.12M | 9.45M | 14.78M | 13.9M | 25.32M | 16.67M | 19.3M | 24.49M | 19.16M | 32.56M |
| Short-Term Investments | 5.5M | 23.36M | 27.2M | 36.3M | 39.72M | 51.61M | 49.82M | 71.94M | 74.87M | 85.44M | 102.23M | 105.28M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 6.7M | 6.52M | 2.67M | 4.52M | 872K | 995K | 1.75M | 1.08M | 768K | 2.05M | 3.59M | 1.09M |
| Total Non-Current Assets | 982K | 1.01M | 1.03M | 738K | 602K | 267K | 777K | 995K | 814K | 831K | 772K | 742K |
| Property, Plant & Equipment | 172K | 198K | 224K | 112K | 189K | 267K | 346K | 427K | 510K | 592K | 670K | 742K |
| Fixed Asset Turnover | 1.15x | 1.05x | 1.26x | 1.41x | 0.93x | 0.12x | 0.77x | 0.64x | - | 0.36x | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 626K | 413K | 0 | 431K | 568K | 304K | 239K | 102K | 0 |
| Other Non-Current Assets | 810K | 810K | 810K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 54.47M | 62.26M | 67.66M | 51M | 57.98M | 68.11M | 79.01M | 92.43M | 99.36M | 115.62M | 133.19M | 147.58M |
| Asset Turnover | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | - | 0.00x | - | - |
| Asset Growth % | -6.06% | -8.58% | -14.36% | -44.82% | -41.64% | -41.09% | -40.68% | -37.37% | -38.79% | -35.92% | -7.29% | -5.16% |
| Total Current Liabilities | 4.14M | 4.22M | 4.52M | 5.04M | 3.91M | 6.24M | 8.19M | 12.16M | 10.09M | 9.26M | 9.4M | 8.05M |
| Accounts Payable | 940K | 126K | 269K | 119K | 400K | 278K | 583K | 1.22M | 470K | 976K | 464K | 689K |
| Days Payables Outstanding | 15.99K | - | - | - | - | 1.32K | - | 2.26K | 1.88K | 581.05 | 1.43K | 1.76K |
| Short-Term Debt | 99K | 94K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 212K | 424K | 636K | 848K | 848K | 1.1M | 1.2M | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.1M | 3.79M | 2.56M | 1.42M | 964K | 3.1M | 6.28M | 6.75M | 3.88M | 3.17M | 3.33M | 2.23M |
| Current Ratio | 12.92x | 14.50x | 14.74x | 9.98x | 14.68x | 10.87x | 9.55x | 7.52x | 9.77x | 12.39x | 14.08x | 18.23x |
| Quick Ratio | 12.92x | 14.50x | 14.74x | 9.98x | 14.68x | 10.87x | 9.55x | 7.52x | 9.77x | 12.39x | 14.08x | 18.23x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 55K | 82K | 108K | 0 | 0 | 212K | 0 | 253K | 116K | 173K | 211K | 266K |
| Long-Term Debt | 55K | 82K | 0 | 0 | 0 | 0 | 0 | 0 | 116K | 0 | 0 | 266K |
| Capital Lease Obligations | 0 | 0 | 108K | 0 | 0 | 0 | 0 | 58K | 116K | 173K | 211K | 266K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -116K | 0 | 0 | -266K |
| Total Liabilities | 4.2M | 4.3M | 4.63M | 5.04M | 3.91M | 6.45M | 8.19M | 12.41M | 10.2M | 9.44M | 9.61M | 8.32M |
| Total Debt | 154K | 176K | 198K | 58K | 116K | 154K | 230K | 284K | 339K | 392K | 428K | 479K |
| Net Debt | -41.15M | -31.2M | -31.92M | -9.39M | -14.66M | -13.75M | -25.09M | -16.39M | -18.96M | -24.1M | -18.73M | -32.08M |
| Debt / Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 50.28M | 57.96M | 63.03M | 45.96M | 54.07M | 61.65M | 70.82M | 80.02M | 89.16M | 106.18M | 123.58M | 139.26M |
| Equity Growth % | -7.02% | -6% | -10.99% | -42.56% | -39.35% | -41.94% | -42.7% | -42.54% | -42.55% | -37.29% | -6.34% | -5.81% |
| Book Value per Share | 8.84 | 10.97 | 11.19 | 8.20 | 9.66 | 11.04 | 12.70 | 14.51 | 17.49 | 20.90 | 24.39 | 27.60 |
| Total Shareholders' Equity | 50.28M | 57.96M | 63.03M | 45.96M | 54.07M | 61.65M | 70.82M | 80.02M | 89.16M | 106.18M | 123.58M | 139.26M |
| Common Stock | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K |
| Retained Earnings | -310.28M | -302M | -296.15M | -312.16M | -302.46M | -293.02M | -281.98M | -270.51M | -254.27M | -235.25M | -215M | -196.63M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 18K | 24K | 17K | 47K | 68K | 169K | -71K | -71K | 15K | -208K | -272K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |